drug

Lars Fruergaard Jørgensen, CEO of Novo Nordisk, speaks during an interview in New York on …

Key Takeaways Biohaven said its experimental treatment for a rare neurological condition showed “a robust …

Key Takeaways A breast cancer drug being developed by AstraZeneca failed to “achieve statistical significance” …

Key Takeaways Novo Nordisk’s U.S.-listed shares lost ground Friday after a Phase 2a trial of …

Lina Khan, Chair of the Federal Trade Commission (FTC), testifies before the House Appropriations Subcommittee …

Key Takeaways Novartis said its Kisqali breast cancer drug produced longer success for those with …

KEY TAKEAWAYS Pfizer said this weekend that a drug aimed at helping cancer patients losing …

Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their …

Mark Zuckerberg, chief executive officer of Meta Platforms Inc., during an interview on “The Circuit …

Key Takeaways Eli Lilly is investing $1.8 billion to expand production in Ireland of its …

Digital health company Noom on Thursday announced it will offer a compounded GLP-1 drug as …

An illustrative image of a person holding a medical syringe and a Covid-19 vaccine vial …

Key Takeaways Summit Therapeutics reported positive results from a Phase 3 trial in China of …

Shortly after the opening bell, we’ll be selling 10 shares of Eli Lilly at roughly …